Singapore led Southeast Asia in healthtech and life sciences funding in 2024, raising $92.4m across 14 rounds, Traxcn reported.
Genting Sing is the most active stock, followed by Sembcorp Ind (2.76%) and YZJ Shipbldg SGD (+2.69%). Wilmar Intl and DFIRG USD were at the foot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback